Fatal invasive pulmonary aspergillosis caused by voriconazole-resistant Aspergillus tubingensis in a patient with solid tumor

Sohei Harada(University of Tokyo Hospital), Brian Hayama(Japanese Foundation For Cancer Research), Kenji Nakano(National Center for Global Health and Medicine), Hiroki Mitani(Japanese Foundation For Cancer Research), Yutaka Yamamoto(Kindai University), Daisuke Ohkushi(Japanese Foundation For Cancer Research), Katsuhiko Kamei(Chiba University)
Journal of Infection and Chemotherapy
November 29, 2019
10.1016/j.jiac.2019.10.022
Cited by 10

Related Papers

Safety and pharmacokinetics of milademetan, a MDM2 inhibitor, in Japanese patients with solid tumors: A phase I study
|Cancer Science|2021|72
High frequency of neurolymphomatosis as a relapse disease of intravascular large B‐cell lymphoma
|Cancer|2011|47
Clinical characteristics and risk factors associated with Pneumocystis jirovecii infection in patients with solid tumors: study of thirteen-year medical records of a large cancer center
|BMC Cancer|2021|28
Comparison of the clinical risk factors between Candida albicans and Candida non-albicans species for bloodstream infection
|The Journal of Antibiotics|2014|26
Clinical characteristics of peripheral venous catheter-associated gram-negative bloodstream infection among patients with malignancy
|PLoS ONE|2020|20